Edward M. Liddy - Jun 30, 2021 Form 4 Insider Report for AbbVie Inc. (ABBV)

Role
Director
Signature
Steven L. Scrogham, attorney-in-fact for Edward M. Liddy
Stock symbol
ABBV
Transactions as of
Jun 30, 2021
Transactions value $
$31,998
Form type
4
Date filed
7/2/2021, 09:09 AM
Previous filing
May 11, 2021
Next filing
Oct 4, 2021

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ABBV Stock Equivalent Units Award $32K +284 +1.07% $112.67 26.9K Jun 30, 2021 Common Stock 284 $112.67 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Director fees credited to stock equivalent unit accounts under grantor trusts established by the director at Abbott Laboratories and AbbVie. The cash equivalent of 1,748 stock equivalent units in the Abbott account was paid to the director upon his retirement from Abbott's board on May 1, 2021. The stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock.
F2 Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature.